Back to Search
ERNEST BRADY, MD
MD
Anesthesiology Physician
NPI: 1225074628Individual
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
E0829(TX)
Research & Publications (20)
Transient simulation of last deglaciation with a new mechanism for Bolling-Allerod warming.
PMID 19608916·Science·2009
8-other
Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease.
PMID 18698028·Clin Cancer Res·2008
7-preclinical
Walking and inflammatory markers in individuals screened for type 2 diabetes.
PMID 18652841·Prev Med·2008
8-other
Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.
PMID 18564868·Bioconjug Chem·2008
7-preclinical
Discovery of potent, orally active benzimidazole glucagon receptor antagonists.
PMID 18539028·Bioorg Med Chem Lett·2008
7-preclinical
Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy.
PMID 18062661·J Med Chem·2008
7-preclinical
Identity as a moderator of gender differences in the emotional closeness of emerging adults' same- and cross-sex friendships.
PMID 17536473·Adolescence·2007
8-other
Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease.
PMID 17363549·Clin Cancer Res·2007
7-preclinical
Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptor.
PMID 17126016·Bioorg Med Chem Lett·2007
7-preclinical
Evaluating Diagnosis and Treatment Patterns of COPD in Primary Care.
PMID 16808547·Treat Respir Med·2006
8-other
In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
PMID 16720237·Nucl Med Biol·2006
7-preclinical
Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
PMID 16539394·J Med Chem·2006
7-preclinical
Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2.
PMID 16248771·Cancer Biother Radiopharm·2005
7-preclinical
Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists.
PMID 16102966·Bioorg Med Chem Lett·2005
7-preclinical
Purification of cyclotron-produced 203Pb for labeling Herceptin.
PMID 15820766·Nucl Med Biol·2005
7-preclinical
Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor.
PMID 15713396·Bioorg Med Chem Lett·2005
8-other
Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.
PMID 15585615·Clin Cancer Res·2004
7-preclinical
A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects.
PMID 15561959·Diabetes·2004
7-preclinical
Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists.
PMID 15464082·Eur J Pharmacol·2004
4-observational
Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copper.
PMID 15246371·Nucl Med Biol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 CITYWEST BLVD, STE. 300
HOUSTON, TX 77042 - Phone
- (713) 620-4000
Quick Facts
- NPI
- 1225074628
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile